Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Dougherty

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Lasers in Surgery and Medicine|April 25, 2006
Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IXDavid A Bellnier, William R Greco, Gregory M Loewen, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2014
Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitorAsha S Nayar, Thomas J Dougherty, Folkert Reck, et al.
Photochemistry and Photobiology|July 20, 2002
The role of the peripheral benzodiazepine receptor in photodynamic activity of certain pyropheophorbide ether photosensitizers: albumin site II as a surrogate marker for activityThomas J Dougherty, Adam B Sumlin, William R Greco, et al.
Lasers in Surgery and Medicine|June 22, 2006
Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapyRavindra K Pandey, Lalit N Goswami, Yihui Chen, et al.
Journal of Medicinal Chemistry|September 17, 2004
Synthesis and photosensitizing efficacy of isomerically pure bacteriopurpurinimidesYihui Chen, Adam Sumlin, Janet Morgan, et al.
Lasers in Surgery and Medicine|November 8, 2011
Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagusHector R Nava, Shyam S Allamaneni, Thomas J Dougherty, et al.
Journal of Medicinal Chemistry|May 27, 2005
Methyl pyropheophorbide-a analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacyYihui Chen, Xiang Zheng, Mahabeer P Dobhal, et al.
Veterinary Ophthalmology|December 17, 2008
Photodynamic therapy for the treatment of periocular squamous cell carcinoma in horses: a pilot studyElizabeth A Giuliano, Ian MacDonald, Dudley L McCaw, et al.
Cancer Research|April 19, 2003
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patientsDavid A Bellnier, William R Greco, Gregory M Loewen, et al.
Journal of the American Chemical Society|June 26, 2003
Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapyIndrajit Roy, Tymish Y Ohulchanskyy, Haridas E Pudavar, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Lasers in Surgery and Medicine|April 25, 2006
Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IXDavid A Bellnier, William R Greco, Gregory M Loewen, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2014
Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitorAsha S Nayar, Thomas J Dougherty, Folkert Reck, et al.
Photochemistry and Photobiology|July 20, 2002
The role of the peripheral benzodiazepine receptor in photodynamic activity of certain pyropheophorbide ether photosensitizers: albumin site II as a surrogate marker for activityThomas J Dougherty, Adam B Sumlin, William R Greco, et al.
Lasers in Surgery and Medicine|June 22, 2006
Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapyRavindra K Pandey, Lalit N Goswami, Yihui Chen, et al.
Journal of Medicinal Chemistry|September 17, 2004
Synthesis and photosensitizing efficacy of isomerically pure bacteriopurpurinimidesYihui Chen, Adam Sumlin, Janet Morgan, et al.
Lasers in Surgery and Medicine|November 8, 2011
Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagusHector R Nava, Shyam S Allamaneni, Thomas J Dougherty, et al.
Journal of Medicinal Chemistry|May 27, 2005
Methyl pyropheophorbide-a analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacyYihui Chen, Xiang Zheng, Mahabeer P Dobhal, et al.
Veterinary Ophthalmology|December 17, 2008
Photodynamic therapy for the treatment of periocular squamous cell carcinoma in horses: a pilot studyElizabeth A Giuliano, Ian MacDonald, Dudley L McCaw, et al.
Cancer Research|April 19, 2003
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patientsDavid A Bellnier, William R Greco, Gregory M Loewen, et al.
Journal of the American Chemical Society|June 26, 2003
Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapyIndrajit Roy, Tymish Y Ohulchanskyy, Haridas E Pudavar, et al.
Pageof 5